These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15168117)
1. Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance. De Raeve HR; Vermeulen PB; Vanderkerken K; Harris AL; Van Marck E Virchows Arch; 2004 Jul; 445(1):27-35. PubMed ID: 15168117 [TBL] [Abstract][Full Text] [Related]
2. Expression of carbonic anhydrase IX in human pancreatic cancer. Juhász M; Chen J; Lendeckel U; Kellner U; Kasper HU; Tulassay Z; Pastorekova S; Malfertheiner P; Ebert MP Aliment Pharmacol Ther; 2003 Oct; 18(8):837-46. PubMed ID: 14535878 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies. De Raeve H; Van Marck E; Van Camp B; Vanderkerken K Histol Histopathol; 2004 Jul; 19(3):935-50. PubMed ID: 15168356 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX in early-stage non-small cell lung cancer. Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition. Colpaert CG; Vermeulen PB; Van Beest P; Soubry A; Goovaerts G; Dirix LY; Harris AL; Van Marck EA Histopathology; 2003 Jun; 42(6):530-40. PubMed ID: 12786888 [TBL] [Abstract][Full Text] [Related]
7. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology. Lin XY; Zhang H; Tang N; Zhang XP; Zhang W; Wang EH; Han YC Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Saarnio J; Parkkila S; Parkkila AK; Haukipuro K; Pastoreková S; Pastorek J; Kairaluoma MI; Karttunen TJ Am J Pathol; 1998 Jul; 153(1):279-85. PubMed ID: 9665489 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma. Furjelová M; Kovalská M; Jurková K; Horáček J; Carbolová T; Adamkov M Acta Histochem; 2014 Jan; 116(1):89-93. PubMed ID: 23816158 [TBL] [Abstract][Full Text] [Related]
10. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156 [TBL] [Abstract][Full Text] [Related]
11. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. Smolej L; Kasparová P APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis. Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Vacca A; Ribatti D; Presta M; Minischetti M; Iurlaro M; Ria R; Albini A; Bussolino F; Dammacco F Blood; 1999 May; 93(9):3064-73. PubMed ID: 10216103 [TBL] [Abstract][Full Text] [Related]
16. Expression of carbonic anhydrase IX in craniopharyngiomas. Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968 [TBL] [Abstract][Full Text] [Related]
17. The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder. Klatte T; Belldegrun AS; Pantuck AJ BJU Int; 2008 Jun; 101 Suppl 4():45-8. PubMed ID: 18430124 [No Abstract] [Full Text] [Related]
18. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489 [TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX: role in diagnosis prognosis and cancer therapy. Introduction. Belldegrun AS; Bevan P BJU Int; 2008 Jun; 101 Suppl 4():1. PubMed ID: 18430114 [No Abstract] [Full Text] [Related]